Biotechnology
The Biotechnology industry has a total of 587 stocks, with a combined market cap of $1.11 trillion and total revenue of $110.01 billion.
Market Cap
1.11T
Revenue
110.01B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.53%
Dividend Yield
0.04%
587 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.27B | -2.04% | 1,108,644 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.11B | -2.30% | 1,079,511 | 14.92B |
| 3 | ARGX | argenx SE | 51.88B | 0.01% | 238,363 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 39.47B | -2.10% | 1,026,768 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 34.80B | 3.94% | 6,570,608 | - |
| 6 | RPRX | Royalty Pharma plc | 31.78B | -1.02% | 3,700,954 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 31.09B | -2.86% | 373,482 | 5.70B |
| 8 | BNTX | BioNTech SE | 23.19B | -4.43% | 1,296,073 | 3.23B |
| 9 | INSM | Insmed Incorporated | 22.98B | -0.82% | 3,348,733 | 819.56M |
| 10 | ROIV | Roivant Sciences Ltd. | 20.92B | -3.00% | 4,114,427 | 8.26M |
| 11 | INCY | Incyte Corporation | 19.12B | -1.10% | 1,248,508 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.28B | -2.39% | 5,496,858 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.65B | -3.34% | 1,711,252 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.60B | -1.63% | 945,173 | 4.44B |
| 15 | ASND | Ascendis Pharma A/S | 13.59B | -2.36% | 661,618 | 998.25M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 12.80B | -1.36% | 8,087,685 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 12.64B | -0.40% | 2,431,392 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.46B | -1.46% | 1,465,455 | 1.06B |
| 19 | SMMT | Summit Therapeutics Inc. | 12.19B | -10.43% | 19,172,197 | - |
| 20 | AXSM | Axsome Therapeutics, Inc. | 11.85B | -1.80% | 493,176 | 708.24M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.10B | -3.23% | 191,417 | 1.13B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.64B | -3.94% | 2,817,561 | 3.24B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.59B | -3.48% | 2,272,678 | 622.01M |
| 24 | ABVX | ABIVAX Société Anonyme | 10.35B | -2.22% | 3,603,437 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.00B | -4.01% | 1,633,947 | 105.82M |
| 26 | PRAX | Praxis Precision Medicines, Inc. | 9.34B | -4.23% | 235,105 | 7.46M |
| 27 | KRYS | Krystal Biotech, Inc. | 8.79B | -3.54% | 206,458 | 417.30M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.08B | 2.40% | 2,383,659 | 1.51B |
| 29 | TECH | Bio-Techne Corporation | 7.95B | -1.71% | 2,186,106 | 1.21B |
| 30 | IBRX | ImmunityBio, Inc. | 7.58B | -3.72% | 20,326,695 | 140.98M |
| 31 | CORT | Corcept Therapeutics Incorporated | 7.56B | 1.37% | 1,095,523 | 769.10M |
| 32 | NUVL | Nuvalent, Inc. | 7.35B | -15.74% | 2,941,620 | - |
| 33 | PCVX | Vaxcyte, Inc. | 7.06B | -4.84% | 1,141,472 | - |
| 34 | IMVT | Immunovant, Inc. | 6.75B | -1.32% | 1,591,711 | - |
| 35 | KYMR | Kymera Therapeutics, Inc. | 6.45B | -3.62% | 437,529 | 51.48M |
| 36 | CNTA | Centessa Pharmaceuticals plc | 6.17B | 0.23% | 1,458,399 | 15.00M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 6.13B | -4.03% | 920,987 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.12B | -0.07% | 706,349 | 827.11M |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 6.10B | -4.66% | 814,212 | 74.06M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.01B | -0.66% | 383,039 | 217.17M |
| 41 | CELC | Celcuity Inc. | 6.00B | -7.47% | 1,792,796 | - |
| 42 | COGT | Cogent Biosciences, Inc. | 5.95B | -0.43% | 3,054,581 | - |
| 43 | APGE | Apogee Therapeutics, Inc. | 5.94B | -3.46% | 803,128 | - |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.87B | -5.09% | 490,114 | 569.61M |
| 45 | BLTE | Belite Bio, Inc | 5.78B | 1.96% | 398,810 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.68B | -3.77% | 1,124,508 | - |
| 47 | TGTX | TG Therapeutics, Inc. | 5.30B | -1.40% | 1,638,249 | 700.35M |
| 48 | CRSP | CRISPR Therapeutics AG | 5.23B | -3.54% | 1,422,488 | 4.10M |
| 49 | CGON | CG Oncology, Inc. | 5.22B | -4.91% | 814,448 | 5.07M |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.16B | -2.41% | 1,341,122 | 7.50M |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -3.83% | 523,297 | 1.34M |
| 52 | LEGN | Legend Biotech Corporation | 4.74B | -6.08% | 3,117,600 | 1.14B |
| 53 | CAI | Caris Life Sciences, Inc. | 4.65B | -1.61% | 2,599,404 | 907.29M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | -0.94% | 166,467 | 274.48M |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.33B | 17.86% | 4,398,590 | - |
| 56 | ERAS | Erasca, Inc. | 4.30B | 7.63% | 10,508,907 | - |
| 57 | MANE | Veradermics, Incorporated | 4.24B | 0.59% | 510,254 | - |
| 58 | TVTX | Travere Therapeutics, Inc. | 4.19B | -4.54% | 1,160,210 | 536.20M |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.14% | 1,590,836 | 596.96M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.72B | -5.63% | 1,206,588 | 22.57M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.68B | -0.65% | 1,119,132 | 1.10B |
| 62 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.64B | -2.90% | 730,297 | 18.07M |
| 63 | VKTX | Viking Therapeutics, Inc. | 3.63B | -4.49% | 1,474,472 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.34B | 5.10% | 2,788,215 | 56.99M |
| 65 | ORKA | Oruka Therapeutics, Inc. | 3.32B | -6.01% | 1,123,184 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.24B | -2.99% | 1,222,530 | - |
| 67 | RCUS | Arcus Biosciences, Inc. | 3.23B | 1.30% | 1,252,206 | 236.00M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.16B | -0.11% | 120,628 | 803.79M |
| 69 | RLAY | Relay Therapeutics, Inc. | 3.11B | 1.49% | 2,258,028 | 10.68M |
| 70 | BEAM | Beam Therapeutics Inc. | 3.10B | -5.44% | 1,372,779 | 164.01M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.08B | -3.62% | 1,437,949 | - |
| 72 | KLRA | Kailera Therapeutics, Inc. | 2.98B | 0.26% | 298,463 | - |
| 73 | IRON | Disc Medicine, Inc. | 2.75B | 3.45% | 584,611 | - |
| 74 | GPCR | Structure Therapeutics Inc. | 2.74B | -2.01% | 669,494 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.69B | 0.05% | 1,602,213 | 415.62M |
| 76 | DFTX | Definium Therapeutics, Inc. | 2.62B | -0.54% | 1,735,093 | - |
| 77 | ALMS | Alumis Inc. | 2.59B | -5.88% | 1,637,459 | 8.40M |
| 78 | MLYS | Mineralys Therapeutics, Inc. | 2.57B | -1.24% | 1,344,963 | - |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.54B | -1.80% | 870,085 | 225.27M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.54B | -0.79% | 386,678 | 535.08M |
| 81 | VERA | Vera Therapeutics, Inc. | 2.44B | -4.45% | 773,055 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -4.10% | 731,049 | 865.00K |
| 83 | IMNM | Immunome, Inc. | 2.35B | -4.81% | 1,523,981 | 4.02M |
| 84 | KOD | Kodiak Sciences Inc. | 2.30B | 0.54% | 670,706 | - |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.28B | -5.21% | 633,783 | - |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | -4.55% | 2,327,481 | 670.00M |
| 87 | NKTR | Nektar Therapeutics | 2.16B | -1.57% | 753,811 | 55.63M |
| 88 | PHVS | Pharvaris N.V. | 2.03B | -3.51% | 129,978 | - |
| 89 | NBTX | Nanobiotix S.A. | 2.02B | -5.45% | 53,987 | 38.27M |
| 90 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | 5.57% | 30,652,029 | 66.41M |
| 91 | TRVI | Trevi Therapeutics, Inc. | 1.98B | -1.56% | 819,001 | - |
| 92 | ABCL | AbCellera Biologics Inc. | 1.97B | 4.70% | 9,343,669 | 79.21M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -0.13% | 1,087,108 | 298.30M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -0.89% | 1,859,252 | 52.04M |
| 95 | MESO | Mesoblast Limited | 1.95B | -3.51% | 153,711 | 65.38M |
| 96 | ZLAB | Zai Lab Limited | 1.92B | -3.28% | 914,076 | 453.28M |
| 97 | NTLA | Intellia Therapeutics, Inc. | 1.92B | -2.42% | 3,553,500 | 66.09M |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.90B | -1.42% | 354,733 | 32.08M |
| 99 | VRDN | Viridian Therapeutics, Inc. | 1.87B | -3.75% | 1,365,879 | 70.92M |
| 100 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -1.45% | 3,093,003 | 2.18B |
| 101 | SION | Sionna Therapeutics, Inc. | 1.85B | -4.48% | 327,699 | - |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 1.84B | 0.70% | 752,254 | 899.11M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.83B | -1.00% | 3,547,594 | 509.86M |
| 104 | LKFT | Lakefront Biotherapeutics NV | 1.82B | -2.82% | 188,121 | 1.20B |
| 105 | TYRA | Tyra Biosciences, Inc. | 1.81B | -9.04% | 1,076,865 | - |
| 106 | NRIX | Nurix Therapeutics, Inc. | 1.80B | -2.08% | 851,620 | 71.78M |
| 107 | ZYME | Zymeworks Inc. | 1.79B | -2.23% | 394,070 | 81.26M |
| 108 | QURE | uniQure N.V. | 1.78B | -1.09% | 1,160,820 | 18.09M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -6.05% | 256,196 | 20.00M |
| 110 | ATAI | AtaiBeckley Inc. | 1.77B | 6.40% | 6,623,265 | 3.49M |
| 111 | IOVA | Iovance Biotherapeutics, Inc. | 1.77B | -3.41% | 13,060,852 | 285.61M |
| 112 | AAPG | Ascentage Pharma Group International | 1.76B | -4.65% | 8,228 | 82.08M |
| 113 | NVAX | Novavax, Inc. | 1.73B | -4.19% | 4,355,635 | 596.34M |
| 114 | NUVB | Nuvation Bio Inc. | 1.73B | 3.77% | 5,399,993 | 143.05M |
| 115 | BHVN | Biohaven Ltd. | 1.72B | 3.81% | 2,699,385 | - |
| 116 | TSHA | Taysha Gene Therapies, Inc. | 1.72B | 1.70% | 1,526,575 | 7.47M |
| 117 | GHRS | GH Research PLC | 1.70B | 3.50% | 282,817 | - |
| 118 | SLS | SELLAS Life Sciences Group, Inc. | 1.69B | -2.58% | 7,044,461 | - |
| 119 | VCEL | Vericel Corporation | 1.68B | -1.44% | 371,656 | 292.09M |
| 120 | SNDX | Syndax Pharmaceuticals, Inc. | 1.67B | -3.78% | 1,455,520 | 217.17M |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.67B | -4.76% | 853,370 | 66.05M |
| 122 | GLUE | Monte Rosa Therapeutics, Inc. | 1.66B | -0.13% | 851,904 | 42.95M |
| 123 | GENB | Generate Biomedicines, Inc. | 1.66B | -1.14% | 653,142 | 30.30M |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.65B | -4.77% | 726,325 | 11.13M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.61B | -5.05% | 242,080 | - |
| 126 | INVA | Innoviva, Inc. | 1.59B | 0.42% | 1,014,065 | 420.69M |
| 127 | ANAB | AnaptysBio, Inc. | 1.55B | -4.54% | 725,051 | 232.39M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.54B | 0.48% | 307,385 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.52B | -5.35% | 1,740,609 | 65.50M |
| 130 | IMTX | Immatics N.V. | 1.49B | -3.21% | 585,971 | 43.00M |
| 131 | FTRE | Fortrea Holdings Inc. | 1.49B | 2.40% | 1,385,568 | 2.71B |
| 132 | IMCR | Immunocore Holdings plc | 1.48B | 0.83% | 873,909 | 412.81M |
| 133 | PGEN | Precigen, Inc. | 1.47B | -5.07% | 4,830,298 | 31.60M |
| 134 | INBX | Inhibrx Biosciences, Inc. | 1.46B | -4.37% | 261,290 | 1.30M |
| 135 | MBX | MBX Biosciences, Inc. | 1.46B | -2.80% | 347,586 | - |
| 136 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | 0.26% | 2,537,496 | 114.48M |
| 137 | AVBP | ArriVent BioPharma, Inc. | 1.43B | 1.35% | 1,164,222 | - |
| 138 | ARDX | Ardelyx, Inc. | 1.42B | -5.13% | 2,264,971 | 427.68M |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.41B | -4.02% | 342,534 | 20.00M |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.39B | -1.88% | 675,335 | - |
| 141 | BCAX | Bicara Therapeutics Inc. | 1.35B | -5.20% | 588,824 | - |
| 142 | SEPN | Septerna, Inc. | 1.35B | -0.73% | 359,290 | 72.26M |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.35B | 1.54% | 224,952 | - |
| 144 | URGN | UroGen Pharma Ltd. | 1.32B | -3.80% | 1,066,816 | 140.49M |
| 145 | SVRA | Savara Inc. | 1.31B | -0.96% | 2,071,653 | - |
| 146 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.23B | -1.04% | 2,052,427 | 204.73M |
| 147 | WVE | Wave Life Sciences Ltd. | 1.20B | -4.86% | 3,750,919 | 71.80M |
| 148 | COAG | Hemab Therapeutics Holdings, Inc. | 1.20B | -4.81% | 128,153 | - |
| 149 | DBVT | DBV Technologies S.A. | 1.16B | -1.57% | 180,926 | 5.74M |
| 150 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -1.25% | 636,659 | 10.00M |
| 151 | AVLN | Avalyn Pharma Inc. | 1.12B | -7.16% | 143,919 | - |
| 152 | OLMA | Olema Pharmaceuticals, Inc. | 1.11B | -3.64% | 1,142,875 | - |
| 153 | EYPT | EyePoint, Inc. | 1.10B | -3.17% | 1,307,242 | 7.61M |
| 154 | MNKD | MannKind Corporation | 1.09B | -6.37% | 7,672,193 | 360.78M |
| 155 | AKTS | Aktis Oncology, Inc. | 1.08B | -6.08% | 98,701 | 8.28M |
| 156 | ABSI | Absci Corporation | 1.02B | -3.41% | 4,964,188 | 1.84M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.02B | -2.66% | 1,339,245 | - |
| 158 | IVA | Inventiva S.A. | 1.01B | -3.25% | 347,973 | 7.94M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 996.23M | -1.40% | 589,862 | - |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 936.43M | 3.97% | 1,730,771 | 98.99M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 929.59M | 6.27% | 3,249,055 | - |
| 162 | PHAR | Pharming Group N.V. | 921.89M | -1.08% | 10,980 | 369.49M |
| 163 | LXRX | Lexicon Pharmaceuticals, Inc. | 919.49M | -5.05% | 1,825,892 | 69.64M |
| 164 | ANNX | Annexon, Inc. | 914.24M | 2.95% | 4,730,019 | - |
| 165 | JBIO | Jade Biosciences, Inc. | 914.14M | -11.98% | 2,629,707 | - |
| 166 | SPTX | Seaport Therapeutics, Inc. | 908.37M | -5.83% | 117,564 | - |
| 167 | MGTX | MeiraGTx Holdings plc | 907.57M | -7.98% | 679,926 | 79.76M |
| 168 | SANA | Sana Biotechnology, Inc. | 893.32M | -2.73% | 3,108,116 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 884.97M | -1.75% | 840,596 | 191.45M |
| 170 | JANX | Janux Therapeutics, Inc. | 878.78M | -1.23% | 566,673 | 13.73M |
| 171 | DRUG | Bright Minds Biosciences Inc. | 878.77M | -8.00% | 312,056 | - |
| 172 | OCS | Oculis Holding AG | 876.23M | -36.09% | 6,659,089 | 1.51M |
| 173 | XNCR | Xencor, Inc. | 874.87M | -0.67% | 537,622 | 97.36M |
| 174 | DRTS | Alpha Tau Medical Ltd. | 871.55M | -10.76% | 1,940,633 | - |
| 175 | AVTX | Avalo Therapeutics, Inc. | 824.75M | -1.63% | 745,302 | 59.00K |
| 176 | TBPH | Theravance Biopharma, Inc. | 821.24M | -0.81% | 346,734 | 109.78M |
| 177 | ODTX | Odyssey Therapeutics, Inc. | 813.05M | 1.32% | 127,381 | 2.98M |
| 178 | LBRX | LB Pharmaceuticals Inc | 803.81M | 0.21% | 113,933 | - |
| 179 | KURA | Kura Oncology, Inc. | 802.08M | -11.42% | 1,774,809 | 71.64M |
| 180 | EVMN | Evommune, Inc. | 798.53M | -4.56% | 425,932 | 10.00M |
| 181 | AURA | Aura Biosciences, Inc. | 793.05M | -3.75% | 310,777 | - |
| 182 | VOR | Vor Biopharma Inc. | 789.49M | -2.67% | 487,597 | - |
| 183 | GERN | Geron Corporation | 776.24M | -3.20% | 8,306,444 | 196.12M |
| 184 | OMER | Omeros Corporation | 775.86M | -2.90% | 1,170,239 | 9.89M |
| 185 | CTMX | CytomX Therapeutics, Inc. | 751.08M | -4.17% | 6,685,843 | 35.54M |
| 186 | REPL | Replimune Group, Inc. | 743.15M | 3.57% | 10,383,434 | - |
| 187 | ALLO | Allogene Therapeutics, Inc. | 742.08M | -0.92% | 8,511,327 | 22.00K |
| 188 | PHAT | Phathom Pharmaceuticals, Inc. | 733.93M | -3.65% | 1,478,990 | 204.89M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 718.50M | -4.99% | 634,965 | - |
| 190 | SLDB | Solid Biosciences Inc. | 707.85M | -2.04% | 640,142 | - |
| 191 | TENX | Tenax Therapeutics, Inc. | 704.77M | 0.84% | 1,615,271 | - |
| 192 | ANRO | Alto Neuroscience, Inc. | 694.04M | -1.35% | 185,661 | - |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 684.52M | -4.74% | 171,739 | - |
| 194 | ZVRA | Zevra Therapeutics, Inc. | 679.23M | -0.86% | 1,674,147 | 122.29M |
| 195 | CBIO | Crescent Biopharma, Inc. | 664.58M | -3.15% | 423,404 | 11.88M |
| 196 | CRMD | CorMedix Inc. | 662.92M | 0.12% | 1,195,980 | 400.05M |
| 197 | DSGN | Design Therapeutics, Inc. | 652.05M | -0.38% | 1,389,724 | - |
| 198 | IMMX | Immix Biopharma, Inc. | 643.47M | 2.44% | 1,135,607 | - |
| 199 | TRAX | First Tracks Biotherapeutics, Inc. | 631.20M | 13.35% | 854,740 | - |
| 200 | CADL | Candel Therapeutics, Inc. | 623.53M | 2.53% | 1,546,414 | - |
| 201 | SGP | SpyGlass Pharma, Inc. | 614.71M | -4.52% | 41,440 | - |
| 202 | PRME | Prime Medicine, Inc. | 614.10M | -4.23% | 2,275,902 | 4.03M |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 606.14M | -4.62% | 2,093,751 | 8.37M |
| 204 | CABA | Cabaletta Bio, Inc. | 598.41M | -2.91% | 2,569,947 | - |
| 205 | DNA | Ginkgo Bioworks Holdings, Inc. | 597.07M | -2.45% | 1,078,164 | 151.40M |
| 206 | ALT | Altimmune, Inc. | 585.37M | -1.31% | 2,264,630 | 36.00K |
| 207 | EIKN | Eikon Therapeutics, Inc. | 585.24M | -0.28% | 212,886 | - |
| 208 | VALN | Valneva SE | 578.55M | -4.80% | 56,556 | 180.25M |
| 209 | AGMB | AgomAb Therapeutics NV | 576.45M | 4.04% | 31,100 | - |
| 210 | CLYM | Climb Bio, Inc. | 562.47M | 7.44% | 2,481,911 | - |
| 211 | PROK | ProKidney Corp. | 558.81M | 1.09% | 1,465,942 | 889.00K |
| 212 | ARVN | Arvinas, Inc. | 553.59M | -4.45% | 789,945 | 89.40M |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 552.47M | -2.07% | 363,827 | 299.77M |
| 214 | ACHV | Achieve Life Sciences, Inc. | 548.71M | 2.00% | 1,518,819 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 545.13M | -7.30% | 156,144 | - |
| 216 | ASMB | Assembly Biosciences, Inc. | 534.07M | -2.57% | 207,688 | 71.10M |
| 217 | MDXG | MiMedx Group, Inc. | 533.23M | -2.72% | 1,276,491 | 389.42M |
| 218 | GYRE | Gyre Therapeutics, Inc. | 530.87M | -1.69% | 119,933 | 117.05M |
| 219 | XOMA | XOMA Royalty Corporation | 522.84M | -0.05% | 119,259 | 48.56M |
| 220 | EDIT | Editas Medicine, Inc. | 512.56M | -3.47% | 2,997,313 | 38.69M |
| 221 | FDMT | 4D Molecular Therapeutics, Inc. | 507.60M | -2.02% | 972,023 | 88.24M |
| 222 | PRTA | Prothena Corporation plc | 502.07M | -5.80% | 290,882 | 57.94M |
| 223 | KYTX | Kyverna Therapeutics, Inc. | 497.56M | -3.52% | 608,862 | - |
| 224 | AUTL | Autolus Therapeutics plc | 489.70M | -1.60% | 1,524,743 | 92.62M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 489.20M | -3.00% | 130,689 | - |
| 226 | CCCC | C4 Therapeutics, Inc. | 482.59M | 0.23% | 3,766,001 | 34.86M |
| 227 | ANL | Adlai Nortye Ltd. | 481.20M | 0.75% | 150,244 | 5.00M |
| 228 | OVID | Ovid Therapeutics Inc. | 477.80M | -6.23% | 1,962,787 | 7.12M |
| 229 | STRO | Sutro Biopharma, Inc. | 472.18M | -2.50% | 201,787 | 102.48M |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.57M | -2.82% | 254,270 | - |
| 231 | FBRX | Forte Biosciences, Inc. | 465.38M | -0.13% | 354,840 | - |
| 232 | OCGN | Ocugen, Inc. | 463.77M | -0.72% | 5,563,973 | 4.47M |
| 233 | SGMT | Sagimet Biosciences Inc. | 444.00M | -1.37% | 730,876 | - |
| 234 | UPB | Upstream Bio, Inc. | 439.71M | -3.35% | 520,203 | 3.32M |
| 235 | NGNE | Neurogene Inc. | 435.18M | -2.82% | 102,225 | 925.00K |
| 236 | STTK | Shattuck Labs, Inc. | 433.24M | -5.04% | 656,775 | 1.00M |
| 237 | ADCT | ADC Therapeutics SA | 432.45M | - | 538,060 | 79.18M |
| 238 | MNPR | Monopar Therapeutics Inc. | 431.54M | -0.95% | 92,870 | - |
| 239 | FULC | Fulcrum Therapeutics, Inc. | 427.79M | -7.23% | 1,917,490 | 80.00M |
| 240 | VTVT | vTv Therapeutics Inc. | 427.38M | 3.27% | 59,605 | 36.84M |
| 241 | IPSC | Century Therapeutics, Inc. | 425.64M | -3.67% | 859,550 | 109.16M |
| 242 | ZURA | Zura Bio Limited | 402.29M | -1.40% | 407,241 | - |
| 243 | LYEL | Lyell Immunopharma, Inc. | 399.95M | -1.10% | 78,265 | 31.00K |
| 244 | CMPX | Compass Therapeutics, Inc. | 399.80M | -6.72% | 5,410,089 | 850.00K |
| 245 | GLSI | Greenwich LifeSciences, Inc. | 394.99M | 8.92% | 210,696 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 387.65M | -4.64% | 447,049 | 9.01M |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 382.76M | -1.32% | 790,328 | 217.78M |
| 248 | PRLD | Prelude Therapeutics Incorporated | 381.83M | -1.79% | 237,289 | 16.72M |
| 249 | OABI | OmniAb, Inc. | 378.38M | -3.33% | 790,792 | 28.94M |
| 250 | LXEO | Lexeo Therapeutics, Inc. | 377.69M | -6.42% | 799,590 | - |
| 251 | RZLT | Rezolute, Inc. | 377.13M | 9.39% | 1,533,638 | - |
| 252 | BNTC | Benitec Biopharma Inc. | 374.12M | -5.80% | 75,430 | - |
| 253 | RGNX | REGENXBIO Inc. | 369.12M | 1.85% | 981,899 | 87.82M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 368.42M | -3.72% | 155,041 | 69.21M |
| 255 | VSTM | Verastem, Inc. | 368.19M | -3.23% | 1,348,127 | 49.59M |
| 256 | LRMR | Larimar Therapeutics, Inc. | 366.38M | 0.86% | 2,206,217 | - |
| 257 | ARTV | Artiva Biotherapeutics, Inc. | 362.47M | -5.93% | 288,432 | 251.00K |
| 258 | PBYI | Puma Biotechnology, Inc. | 362.40M | -0.70% | 226,518 | 227.18M |
| 259 | IVVD | Invivyd, Inc. | 359.42M | 7.02% | 2,243,228 | 55.87M |
| 260 | CNXU | Conexeu Sciences Inc. | 356.81M | 20.43% | 281,546 | - |
| 261 | NAUT | Nautilus Biotechnology, Inc. | 352.01M | 1.09% | 481,266 | - |
| 262 | AVIR | Atea Pharmaceuticals, Inc. | 350.52M | -6.21% | 366,171 | - |
| 263 | PALI | Palisade Bio, Inc. | 348.24M | -1.89% | 2,405,143 | - |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 341.81M | -0.91% | 323,857 | 51.00M |
| 265 | IFRX | InflaRx N.V. | 335.83M | -5.00% | 894,454 | 33.82K |
| 266 | NMRA | Neumora Therapeutics, Inc. | 333.41M | -1.35% | 802,979 | - |
| 267 | RCKT | Rocket Pharmaceuticals, Inc. | 329.76M | -1.63% | 2,671,760 | - |
| 268 | HUMA | Humacyte, Inc. | 321.93M | 11.54% | 11,049,904 | 2.02M |
| 269 | ABEO | Abeona Therapeutics Inc. | 320.88M | -2.60% | 780,679 | 14.54M |
| 270 | FATE | Fate Therapeutics, Inc. | 319.37M | -3.52% | 7,327,836 | 6.32M |
| 271 | BCYC | Bicycle Therapeutics plc | 315.20M | -3.73% | 268,130 | 63.50M |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 314.68M | -2.50% | 178,761 | - |
| 273 | LCTX | Lineage Cell Therapeutics, Inc. | 314.12M | -5.26% | 941,358 | 14.78M |
| 274 | SLN | Silence Therapeutics plc | 308.91M | -5.22% | 269,442 | 839.00K |
| 275 | IRD | Opus Genetics, Inc. | 294.18M | -5.50% | 778,092 | 11.98M |
| 276 | IKT | Inhibikase Therapeutics, Inc. | 291.42M | -2.29% | 515,717 | 1.00 |
| 277 | IMRX | Immuneering Corporation | 290.81M | -22.10% | 8,885,010 | - |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 290.66M | -1.31% | 842,171 | - |
| 279 | NAGE | Niagen Bioscience, Inc. | 288.12M | -6.48% | 875,710 | 130.42M |
| 280 | SRZN | Surrozen, Inc. | 286.89M | -5.72% | 88,709 | 7.49M |
| 281 | ARMP | Armata Pharmaceuticals, Inc. | 286.22M | -4.53% | 85,500 | 5.20M |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 283.32M | -0.50% | 699,821 | 26.87M |
| 283 | AVXL | Anavex Life Sciences Corp. | 276.16M | -1.65% | 1,590,816 | - |
| 284 | MGNX | MacroGenics, Inc. | 263.14M | -0.48% | 526,230 | 157.08M |
| 285 | CLLS | Cellectis S.A. | 260.83M | -1.14% | 39,374 | 75.11M |
| 286 | NVCT | Nuvectis Pharma, Inc. | 258.62M | - | 92,807 | - |
| 287 | CNTX | Context Therapeutics Inc. | 256.34M | -2.11% | 619,790 | - |
| 288 | TARA | Protara Therapeutics, Inc. | 254.04M | -2.80% | 742,522 | - |
| 289 | ADAG | Adagene Inc. | 250.75M | -4.41% | 41,876 | 7.67M |
| 290 | TRDA | Entrada Therapeutics, Inc. | 248.99M | -2.26% | 252,013 | 5.74M |
| 291 | ACIU | AC Immune SA | 244.03M | -7.52% | 449,620 | 4.62M |
| 292 | CDXS | Codexis, Inc. | 242.69M | -3.61% | 427,411 | 78.09M |
| 293 | ALXO | ALX Oncology Holdings Inc. | 242.21M | -5.26% | 1,015,933 | - |
| 294 | CHRS | Coherus Oncology, Inc. | 242.17M | -1.26% | 809,164 | 46.88M |
| 295 | CRBU | Caribou Biosciences, Inc. | 241.01M | 2.97% | 1,960,929 | 11.20M |
| 296 | SABS | SAB Biotherapeutics, Inc. | 240.34M | -5.00% | 505,696 | 114.70K |
| 297 | HELP | Cybin Inc. | 234.67M | 3.08% | 662,959 | - |
| 298 | FHTX | Foghorn Therapeutics Inc. | 233.39M | -7.13% | 139,218 | 28.22M |
| 299 | LENZ | LENZ Therapeutics, Inc. | 233.28M | -4.37% | 970,832 | 20.99M |
| 300 | CGEN | Compugen Ltd. | 231.73M | -6.84% | 738,198 | 72.66M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 230.14M | -4.68% | 39,958 | 18.47M |
| 302 | ALEC | Alector, Inc. | 229.82M | -4.17% | 705,764 | 18.42M |
| 303 | OBIO | Orchestra BioMed Holdings, Inc. | 229.34M | -2.05% | 279,943 | 32.72M |
| 304 | VYGR | Voyager Therapeutics, Inc. | 229.00M | -2.07% | 444,473 | 36.49M |
| 305 | NERV | Minerva Neurosciences, Inc. | 225.49M | -1.43% | 83,125 | - |
| 306 | NKTX | Nkarta, Inc. | 224.65M | -3.38% | 395,570 | - |
| 307 | WHWK | Whitehawk Therapeutics, Inc. | 221.93M | -4.87% | 264,114 | 7.15M |
| 308 | KPTI | Karyopharm Therapeutics Inc. | 221.68M | 8.02% | 330,028 | 151.12M |
| 309 | ARCT | Arcturus Therapeutics Holdings Inc. | 220.85M | -1.89% | 393,868 | 54.71M |
| 310 | ELTX | Elicio Therapeutics, Inc. | 219.83M | 4.46% | 87,817 | - |
| 311 | INDP | Indaptus Therapeutics, Inc. | 217.43M | 9.09% | 138,168 | - |
| 312 | RNA | Atrium Therapeutics, Inc. | 216.39M | -2.69% | 209,262 | 36.68M |
| 313 | KROS | Keros Therapeutics, Inc. | 215.73M | -3.11% | 231,922 | 33.18M |
| 314 | YDES | YD Bio Limited | 215.53M | -4.81% | 6,701 | 510.36K |
| 315 | CAMP | Camp4 Therapeutics Corporation | 211.34M | -7.29% | 81,225 | 3.93M |
| 316 | ENLV | Enlivex Ltd. | 208.12M | 6.55% | 812,607 | - |
| 317 | NGEN | NervGen Pharma Corp. | 206.03M | -6.28% | 1,144,163 | - |
| 318 | IMUX | Immunic, Inc. | 205.41M | 0.80% | 165,408 | - |
| 319 | RNAC | Cartesian Therapeutics, Inc. | 203.91M | -7.96% | 132,212 | 1.78M |
| 320 | UNCY | Unicycive Therapeutics, Inc. | 202.92M | 2.98% | 931,761 | - |
| 321 | QTTB | Q32 Bio Inc. | 198.39M | 5.88% | 1,069,137 | 53.74M |
| 322 | NBP | NovaBridge Biosciences | 197.76M | -7.07% | 590,539 | - |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.91M | -0.32% | 312,242 | 17.56M |
| 324 | EQ | Equillium, Inc. | 194.74M | 6.21% | 4,126,493 | 4.39M |
| 325 | TNYA | Tenaya Therapeutics, Inc. | 188.79M | 0.12% | 4,634,256 | 225.00K |
| 326 | TTRX | Turn Therapeutics Inc. | 188.56M | 21.73% | 268,071 | - |
| 327 | KRRO | Korro Bio, Inc. | 186.41M | -3.62% | 60,812 | 3.84M |
| 328 | MIST | Milestone Pharmaceuticals Inc. | 185.03M | -4.23% | 1,268,218 | 1.78M |
| 329 | DTIL | Precision BioSciences, Inc. | 181.91M | 1.15% | 312,959 | 45.07M |
| 330 | ABOS | Acumen Pharmaceuticals, Inc. | 181.29M | -3.46% | 412,544 | - |
| 331 | TLSA | Tiziana Life Sciences Ltd | 181.03M | -0.71% | 112,943 | - |
| 332 | MDWD | MediWound Ltd. | 177.62M | -3.56% | 177,781 | 14.48M |
| 333 | IPHA | Innate Pharma S.A. | 172.68M | -1.64% | 47,096 | 10.57M |
| 334 | GALT | Galectin Therapeutics Inc. | 170.90M | 2.98% | 315,278 | - |
| 335 | OKUR | OnKure Therapeutics, Inc. | 169.66M | - | 221,736 | - |
| 336 | NRXP | NRx Pharmaceuticals, Inc. | 167.23M | 4.52% | 1,735,772 | 2.29M |
| 337 | PLX | Protalix BioTherapeutics, Inc. | 165.98M | -2.37% | 536,494 | 76.38M |
| 338 | SPRO | Spero Therapeutics, Inc. | 163.86M | - | 619,223 | 61.19M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 159.20M | -2.02% | 169,911 | 2.00M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 158.92M | -9.52% | 1,447,227 | - |
| 341 | HRTX | Heron Therapeutics, Inc. | 156.57M | -4.93% | 1,899,349 | 150.71M |
| 342 | MENS | Jyong Biotech Ltd. | 152.92M | -6.36% | 79,201 | - |
| 343 | ANTX | AN2 Therapeutics, Inc. | 151.54M | -2.77% | 233,184 | - |
| 344 | MOLN | Molecular Partners AG | 150.74M | -5.95% | 1,005 | 856.30K |
| 345 | PRQR | ProQR Therapeutics N.V. | 149.61M | -10.13% | 777,024 | 15.73M |
| 346 | CNTB | Connect Biopharma Holdings Limited | 147.34M | -6.02% | 120,160 | 233.00K |
| 347 | AGEN | Agenus Inc. | 144.55M | -0.57% | 839,775 | 123.87M |
| 348 | KZIA | Kazia Therapeutics Limited | 144.44M | -1.10% | 88,811 | 1.27M |
| 349 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 143.59M | -2.02% | 595,647 | - |
| 350 | HURA | TuHURA Biosciences, Inc. | 142.65M | -0.88% | 367,573 | - |
| 351 | ACOG | Alpha Cognition Inc. | 138.05M | 2.42% | 21,065 | 10.83M |
| 352 | GUTS | Fractyl Health, Inc. | 137.58M | 7.57% | 1,352,568 | 3.00K |
| 353 | SPRB | Spruce Biosciences, Inc. | 137.01M | -1.11% | 31,154 | 697.00K |
| 354 | PLYX | Polaryx Therapeutics, Inc. | 132.56M | -14.37% | 386,619 | - |
| 355 | GNLX | Genelux Corporation | 131.89M | -2.95% | 135,831 | 8.00K |
| 356 | BDTX | Black Diamond Therapeutics, Inc. | 129.50M | 1.80% | 967,610 | 70.00M |
| 357 | ONCY | Oncolytics Biotech Inc. | 123.10M | 1.92% | 6,330,061 | - |
| 358 | ALPS | Alps Group Inc | 121.47M | -3.93% | 6,970 | 3.74M |
| 359 | ENGN | enGene Therapeutics Inc. | 119.24M | -3.78% | 981,300 | - |
| 360 | NTHI | NeOnc Technologies Holdings, Inc. | 116.58M | -0.75% | 30,510 | 39.99K |
| 361 | COYA | Coya Therapeutics, Inc. | 115.17M | 1.87% | 393,050 | 7.94M |
| 362 | PYXS | Pyxis Oncology, Inc. | 113.41M | -0.56% | 483,384 | 13.86M |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 112.66M | -7.02% | 59,217 | - |
| 364 | CBUS | Cibus, Inc. | 111.75M | 1.74% | 275,657 | 3.64M |
| 365 | CGTX | Cognition Therapeutics, Inc. | 111.69M | 5.93% | 2,422,320 | - |
| 366 | VANI | Vivani Medical, Inc. | 111.24M | -2.27% | 210,078 | - |
| 367 | SEER | Seer, Inc. | 106.07M | 0.53% | 114,410 | 16.58M |
| 368 | INO | Inovio Pharmaceuticals, Inc. | 104.88M | -2.29% | 1,676,172 | 65.34K |
| 369 | OTLK | Outlook Therapeutics, Inc. | 101.89M | 15.48% | 43,815,004 | 333.14K |
| 370 | VRCA | Verrica Pharmaceuticals Inc. | 101.35M | 2.43% | 23,794 | 37.16M |
| 371 | PEPG | PepGen Inc. | 101.33M | -2.33% | 506,582 | - |
| 372 | CRDF | Cardiff Oncology, Inc. | 101.19M | -22.11% | 5,812,365 | 525.00K |
| 373 | BMEA | Biomea Fusion, Inc. | 100.50M | 0.72% | 1,082,636 | - |
| 374 | ALDX | Aldeyra Therapeutics, Inc. | 100.13M | -5.14% | 778,975 | - |
| 375 | RNTX | Rein Therapeutics Inc. | 99.55M | -3.60% | 487,915 | - |
| 376 | PYPD | PolyPid Ltd. | 97.21M | 7.42% | 370,030 | - |
| 377 | PMN | ProMIS Neurosciences, Inc. | 94.38M | -2.64% | 14,598 | - |
| 378 | ACET | Adicet Bio, Inc. | 93.14M | -4.73% | 62,738 | - |
| 379 | PTHS | Pelthos Therapeutics Inc. | 91.06M | -1.02% | 12,272 | 27.70M |
| 380 | ANIX | Anixa Biosciences, Inc. | 90.53M | - | 131,181 | - |
| 381 | OKYO | OKYO Pharma Limited | 89.74M | -0.29% | 44,942 | - |
| 382 | RANI | Rani Therapeutics Holdings, Inc. | 89.40M | -5.80% | 2,018,813 | 3.17M |
| 383 | RLYB | Rallybio Corporation | 89.24M | 16.67% | 451,683 | 858.00K |
| 384 | ICCC | ImmuCell Corporation | 87.89M | -5.13% | 16,733 | 29.93M |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 87.76M | -1.90% | 78,347 | 23.14M |
| 386 | LONA | LeonaBio, Inc. | 87.27M | -2.62% | 18,913 | - |
| 387 | AARD | Aardvark Therapeutics, Inc. | 87.05M | -2.92% | 170,341 | - |
| 388 | HYFT | MindWalk Holdings Corp. | 86.42M | -1.14% | 405,731 | 20.70M |
| 389 | OSTX | OS Therapies Incorporated | 85.74M | -10.05% | 1,807,209 | - |
| 390 | FBIO | Fortress Biotech, Inc. | 85.37M | -8.21% | 794,743 | 66.16M |
| 391 | NRXS | NeurAxis, Inc. | 84.45M | -0.94% | 251,977 | 4.28M |
| 392 | GANX | Gain Therapeutics, Inc. | 83.60M | 0.51% | 1,147,564 | - |
| 393 | LIXT | Lixte Biotechnology Holdings, Inc. | 82.72M | 13.92% | 803,855 | - |
| 394 | EXOZ | eXoZymes, Inc. | 81.91M | -1.88% | 3,180 | -700.00 |
| 395 | CSBR | Champions Oncology, Inc. | 80.61M | -0.51% | 9,496 | 57.95M |
| 396 | MAIA | MAIA Biotechnology, Inc. | 79.04M | -6.47% | 750,010 | - |
| 397 | CUE | Cue Biopharma, Inc. | 78.34M | 9.89% | 105,931 | 32.73M |
| 398 | ANVS | Annovis Bio, Inc. | 77.43M | -5.21% | 1,650,516 | - |
| 399 | PLRX | Pliant Therapeutics, Inc. | 74.30M | -4.76% | 755,709 | - |
| 400 | MCRB | Seres Therapeutics, Inc. | 73.99M | 4.37% | 29,973 | 1.15M |
| 401 | XBIT | XBiotech Inc. | 72.56M | -1.65% | 59,273 | - |
| 402 | FLNA | Filana Therapeutics, Inc. | 71.98M | -3.25% | 578,520 | - |
| 403 | BYSI | BeyondSpring Inc. | 70.31M | 1.79% | 19,934 | 1.88M |
| 404 | ATHE | Alterity Therapeutics Limited | 69.97M | -2.52% | 8,404 | 4.43M |
| 405 | IBIO | iBio, Inc. | 68.31M | -0.53% | 518,281 | 300.00K |
| 406 | MNOV | MediciNova, Inc. | 67.43M | 0.74% | 40,556 | 596.64K |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 66.77M | -2.50% | 396,549 | - |
| 408 | TCRX | TScan Therapeutics, Inc. | 66.00M | -6.48% | 469,184 | 9.14M |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 65.60M | 2.50% | 432,965 | - |
| 410 | PDSB | PDS Biotechnology Corporation | 63.63M | 5.56% | 1,343,791 | - |
| 411 | ENTX | Entera Bio Ltd. | 62.52M | -5.93% | 93,309 | 42.00K |
| 412 | INKT | MiNK Therapeutics, Inc. | 61.78M | 1.64% | 64,605 | - |
| 413 | IMA | ImageneBio, Inc. | 61.70M | -6.97% | 46,801 | 800.00K |
| 414 | IBO | Impact BioMedical Inc. | 59.75M | 6.58% | 56,970 | 39.00K |
| 415 | EDSA | Edesa Biotech, Inc. | 59.45M | -7.34% | 362,662 | - |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 56.78M | 0.59% | 36,352 | - |
| 417 | IMMP | Immutep Limited | 56.18M | -9.41% | 2,146,809 | 5.28M |
| 418 | TIL | Instil Bio, Inc. | 55.00M | 0.50% | 16,068 | - |
| 419 | HYPD | Hyperion DeFi, Inc. | 54.77M | 10.14% | 1,190,307 | 1.04M |
| 420 | ATYR | aTyr Pharma, Inc. | 53.59M | 0.76% | 4,352,502 | 190.00K |
| 421 | RADX | Radiopharm Theranostics Limited | 53.21M | 2.18% | 34,622 | 10.86M |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 49.69M | -2.94% | 165,357 | 22.33M |
| 423 | XLO | Xilio Therapeutics, Inc. | 49.60M | -2.01% | 21,221 | 53.48M |
| 424 | MREO | Mereo BioPharma Group plc | 49.13M | -10.52% | 3,479,181 | 500.00K |
| 425 | ESLA | Estrella Immunopharma, Inc. | 47.98M | 2.29% | 50,393 | - |
| 426 | CING | Cingulate Inc. | 47.79M | -13.46% | 2,151,226 | - |
| 427 | ACTU | Actuate Therapeutics, Inc. | 47.37M | -1.98% | 151,705 | - |
| 428 | GOSS | Gossamer Bio, Inc. | 46.49M | -14.21% | 19,659,182 | 55.54M |
| 429 | GRDX | GridAI Technologies Corp. | 45.24M | 21.21% | 490,035 | - |
| 430 | QNTM | Quantum BioPharma Ltd. | 44.10M | -23.47% | 691,358 | - |
| 431 | ATOS | Atossa Therapeutics, Inc. | 44.00M | -2.29% | 58,515 | - |
| 432 | NTRB | Nutriband Inc. | 43.15M | 1.72% | 8,947 | 2.04M |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 42.98M | -3.85% | 182,629 | - |
| 434 | LTRN | Lantern Pharma Inc. | 41.92M | 4.18% | 197,025 | - |
| 435 | GRCE | Grace Therapeutics, Inc. | 41.63M | 4.67% | 496,764 | - |
| 436 | RNXT | RenovoRx, Inc. | 41.48M | 1.24% | 506,854 | 1.49M |
| 437 | KALA | KALA BIO, Inc. | 40.90M | -1.35% | 99,235 | - |
| 438 | PSTV | Plus Therapeutics, Inc. | 39.11M | -2.06% | 116,310 | 5.21M |
| 439 | GNTA | Genenta Science S.p.A. | 38.93M | 60.19% | 64,084,290 | - |
| 440 | NNVC | NanoViricides, Inc. | 38.27M | -5.62% | 631,778 | - |
| 441 | VERU | Veru Inc. | 38.20M | 0.42% | 100,166 | 16.89M |
| 442 | INMB | INmune Bio Inc. | 36.95M | -1.42% | 177,401 | 50.00K |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | -6.35% | 93,840 | 90.00K |
| 444 | ABVC | ABVC BioPharma, Inc. | 34.37M | -3.55% | 144,590 | 797.92K |
| 445 | TVGN | Tevogen Bio Holdings Inc. | 33.92M | 2.40% | 17,100 | - |
| 446 | ALGS | Aligos Therapeutics, Inc. | 33.11M | -6.14% | 165,846 | 4.71M |
| 447 | DARE | Daré Bioscience, Inc. | 32.81M | -1.79% | 170,951 | 1.16M |
| 448 | LITS | Lite Strategy, Inc. | 32.60M | -5.15% | 535,101 | - |
| 449 | EVAX | Evaxion A/S | 32.53M | -2.50% | 35,698 | 7.53M |
| 450 | LSTA | Lisata Therapeutics, Inc. | 32.34M | 10.15% | 934,519 | 170.00K |
| 451 | BOLD | Boundless Bio, Inc. | 32.28M | -0.69% | 71,673 | - |
| 452 | APLM | Apollomics, Inc. | 31.47M | 1.27% | 1,638 | 8.84M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 30.53M | 3.02% | 273,919 | 38.00K |
| 454 | CELU | Celularity Inc. | 30.39M | 3.96% | 107,086 | 26.55M |
| 455 | TVRD | Tvardi Therapeutics, Inc. | 29.93M | -5.62% | 88,416 | - |
| 456 | IGC | IGC Pharma, Inc. | 29.14M | 2.11% | 450,184 | 1.11M |
| 457 | PLRZ | Polyrizon Ltd. | 29.03M | -9.67% | 18,291 | - |
| 458 | NRSN | NeuroSense Therapeutics Ltd. | 28.73M | -1.05% | 92,404 | - |
| 459 | NEUP | Neuphoria Therapeutics Inc. | 28.64M | -0.19% | 37,440 | -13.27K |
| 460 | DYAI | Dyadic International, Inc. | 28.28M | -3.96% | 290,564 | 3.81M |
| 461 | KYNB | Kyntra Bio, Inc. | 27.93M | - | 18,730 | 7.44M |
| 462 | BRNS | Barinthus Biotherapeutics plc | 27.81M | - | 1,239 | 14.97M |
| 463 | CRVO | CervoMed Inc. | 27.78M | -3.54% | 93,652 | 2.09M |
| 464 | SER | Serina Therapeutics, Inc. | 26.97M | -1.63% | 51,101 | 130.00K |
| 465 | SNSE | Sensei Biotherapeutics, Inc. | 26.97M | -4.94% | 65,118 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 26.70M | -1.99% | 137,198 | - |
| 467 | ALLR | Allarity Therapeutics, Inc. | 26.59M | 4.88% | 308,726 | 345.00K |
| 468 | BCTX | BriaCell Therapeutics Corp. | 26.46M | -9.07% | 744,822 | - |
| 469 | PLUR | Pluri Inc. | 26.00M | 3.88% | 49,530 | 1.08M |
| 470 | PTN | Palatin Technologies, Inc. | 25.90M | 3.42% | 21,309 | 12.88M |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 25.65M | 2.78% | 610,422 | 789.00K |
| 472 | MRKR | Marker Therapeutics, Inc. | 25.50M | -2.60% | 77,048 | 3.55M |
| 473 | CLRB | Cellectar Biosciences, Inc. | 23.74M | -5.41% | 145,043 | - |
| 474 | KTTA | Pasithea Therapeutics Corp. | 23.73M | -0.73% | 547,627 | - |
| 475 | HOWL | Werewolf Therapeutics, Inc. | 22.96M | 5.00% | 378,792 | 1.14M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.75M | 0.13% | 189,795 | 454.00K |
| 477 | LGVN | Longeveron Inc. | 22.55M | -0.28% | 286,243 | 1.22M |
| 478 | TRAW | Traws Pharma, Inc. | 22.27M | 0.68% | 334,879 | 2.73M |
| 479 | CVM | CEL-SCI Corporation | 21.45M | -3.90% | 250,270 | - |
| 480 | XCUR | Exicure, Inc. | 21.23M | 4.39% | 17,976 | 500.00K |
| 481 | CRIS | Curis, Inc. | 20.93M | -7.65% | 284,318 | 7.06M |
| 482 | TPST | Tempest Therapeutics, Inc. | 20.80M | -5.23% | 189,770 | - |
| 483 | AEON | AEON Biopharma, Inc. | 19.73M | -0.89% | 24,346 | - |
| 484 | PASG | Passage Bio, Inc. | 18.77M | 1.39% | 18,440 | - |
| 485 | NCEL | NewcelX Ltd. | 18.74M | -1.14% | 16,585 | - |
| 486 | LPCN | Lipocine Inc. | 18.30M | 1.33% | 147,125 | 2.00M |
| 487 | QNCX | Quince Therapeutics, Inc. | 18.09M | -3.48% | 704,272 | - |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 17.40M | -3.19% | 492,619 | 5.61M |
| 489 | INAB | IN8bio, Inc. | 17.04M | -7.49% | 91,346 | - |
| 490 | HIND | Vyome Holdings, Inc. | 16.56M | 0.85% | 14,313 | 152.72K |
| 491 | GTBP | GT Biopharma, Inc. | 15.94M | -7.57% | 3,041,513 | - |
| 492 | AKTX | Akari Therapeutics, Plc | 15.37M | -18.26% | 188,215 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 15.30M | -0.89% | 186,489 | 225.00K |
| 494 | OSRH | OSR Holdings, Inc. | 15.06M | -1.54% | 867,109 | 2.63M |
| 495 | LEXX | Lexaria Bioscience Corp. | 15.02M | 0.66% | 49,302 | 368.00K |
| 496 | JSPR | Jasper Therapeutics, Inc. | 14.96M | -35.56% | 2,330,181 | - |
| 497 | BLRX | BioLineRx Ltd. | 14.95M | -8.99% | 50,937 | 1.40M |
| 498 | HCWB | HCW Biologics Inc. | 14.82M | 4.55% | 3,310,739 | 6.59M |
| 499 | ICU | SeaStar Medical Holding Corporation | 14.65M | -1.21% | 73,052 | 1.44M |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 14.47M | -5.24% | 57,000 | - |